# LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)

> **NCT04041609** · PHASE2 · COMPLETED · sponsor: **Lyra Therapeutics** · enrollment: 71 (actual)

## Conditions studied

- Chronic Sinusitis
- Chronic Rhinosinusitis (Diagnosis)

## Interventions

- **DRUG:** LYR-210
- **OTHER:** Sham comparator

## Key facts

- **NCT ID:** NCT04041609
- **Lead sponsor:** Lyra Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-09
- **Primary completion:** 2020-03-25
- **Final completion:** 2021-02-04
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2023-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04041609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04041609, "LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04041609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*